Pliant Therapeutics Profit Margin 2019-2021 | PLRX
Current and historical gross margin, operating margin and net profit margin for Pliant Therapeutics (PLRX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Pliant Therapeutics net profit margin as of June 30, 2021 is -613.56%.
|Pliant Therapeutics Annual Profit Margins
|Pliant Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Pliant Therapeutics Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing novel therapies for the treatment of fibrosis. The company's lead product consist PLN-74809 and PLN-1474 which are in clinical stage. Pliant Therapeutics Inc. is based in SAN FRANCISCO, Calif.